IL61114A0 - New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them - Google Patents

New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them

Info

Publication number
IL61114A0
IL61114A0 IL61114A IL6111480A IL61114A0 IL 61114 A0 IL61114 A0 IL 61114A0 IL 61114 A IL61114 A IL 61114A IL 6111480 A IL6111480 A IL 6111480A IL 61114 A0 IL61114 A0 IL 61114A0
Authority
IL
Israel
Prior art keywords
radical
group
phenoxyalkylpiperidine
derivatives
processes
Prior art date
Application number
IL61114A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Publication of IL61114A0 publication Critical patent/IL61114A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms
    • C07D211/58—Nitrogen atoms attached in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
IL61114A 1979-09-28 1980-09-23 New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them IL61114A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19792939292 DE2939292A1 (de) 1979-09-28 1979-09-28 N-phenoxyalkylpiperidin-derivate, verfahrenn zu deren herstellung sowie diese verbindungen enthaltende arzneimittel

Publications (1)

Publication Number Publication Date
IL61114A0 true IL61114A0 (en) 1980-11-30

Family

ID=6082088

Family Applications (1)

Application Number Title Priority Date Filing Date
IL61114A IL61114A0 (en) 1979-09-28 1980-09-23 New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them

Country Status (10)

Country Link
US (1) US4348401A (cs)
EP (1) EP0026876B1 (cs)
JP (1) JPS5668669A (cs)
AT (1) ATE2519T1 (cs)
CA (1) CA1139759A (cs)
CS (1) CS219950B2 (cs)
DD (1) DD153117A5 (cs)
DE (2) DE2939292A1 (cs)
ES (1) ES8105729A1 (cs)
IL (1) IL61114A0 (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209271A1 (de) * 1982-03-13 1983-09-15 Boehringer Mannheim Gmbh, 6800 Mannheim Bicyclische phenolether, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2681319B1 (fr) * 1991-09-12 1995-02-17 Synthelabo Derives de 1-(phenoxyalkyl)piperidine, leur preparation et leur application en therapeutique.
GB9319534D0 (en) * 1993-09-22 1993-11-10 Boots Co Plc Therapeutic agents
HU215397B (hu) * 1994-08-29 1998-12-28 Richter Gedeon Vegyészeti Gyár Rt. (Piperidino-alkil)-aril-éterek, ezeket tartalmazó gyógyszerkészítmények és eljárás ezek előállítására
ZA9610736B (en) * 1995-12-22 1997-06-27 Warner Lambert Co 2-Substituted piperidine analogs and their use as subtypeselective nmda receptor antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610738B (en) 1995-12-22 1997-06-24 Warner Lambert Co Subtype selective nmda receptor ligands and the use thereof
CA2475766C (en) * 2002-03-13 2012-06-05 Janssen Pharmaceutica N.V. Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
MXPA04008797A (es) 2002-03-13 2004-11-26 Janssen Pharmaceutica Nv Inhibidores de histona desacetilasa.
EA007099B1 (ru) 2002-03-13 2006-06-30 Янссен Фармацевтика Н. В. Сульфонилпроизводные в качестве ингибиторов гистон-деацетилазы
HRP20040805A2 (en) * 2002-03-13 2005-04-30 Janssen Pharmaceutica N.V. Carbonylamino derivatives as novel inhibitors histone deacetylase
KR101261305B1 (ko) 2004-07-28 2013-05-08 얀센 파마슈티카 엔.브이. 히스톤 디아세틸라제의 신규한 저해제로의 치환된 인돌릴알킬 아미노 유도체
CA2602121C (en) * 2005-04-07 2014-09-23 Toyama Chemical Co., Ltd. Pharmaceutical composition and method using an antifungal arylamidine in combination
ES2553178T3 (es) 2005-05-18 2015-12-04 Janssen Pharmaceutica N.V. Derivados sustituidos de aminopropenil piperidina o morfolina como nuevos inhibidores de histona deacetilasa
WO2007082874A1 (en) 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
CA2631876C (en) * 2006-01-19 2014-05-27 Janssen Pharmaceutica N.V. Aminophenyl derivatives as inhibitors of histone deacetylase
WO2007082876A1 (en) * 2006-01-19 2007-07-26 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
EP1981875B1 (en) * 2006-01-19 2014-04-16 Janssen Pharmaceutica N.V. Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
WO2007136790A2 (en) 2006-05-18 2007-11-29 Mannkind Corporation Intracellular kinase inhibitors
KR102077864B1 (ko) 2012-08-01 2020-02-14 쇼와 덴코 패키징 가부시키가이샤 내용물 부착 방지 덮개재

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3255196A (en) * 1966-06-07 Phenoxyalkyl piperidine derivatives
CH411880A (fr) * 1962-02-28 1966-04-30 Rhone Poulenc Sa Procédé de préparation de nouveaux dérivés de la pipéridine
US3691176A (en) * 1970-05-25 1972-09-12 Abbott Lab 1-(4-fluorophenoxypropyl)-4-anilino-piperidines
DE2341376A1 (de) * 1972-08-24 1974-03-07 Ciba Geigy Ag Piperidin-derivate und verfahren zu ihrer herstellung
GB1533383A (en) * 1974-11-15 1978-11-22 Science Union & Cie Arylethers and heterocyclic ethers processes for their preparation and pharmaceutical compositions containing them
US4027028A (en) * 1975-11-10 1977-05-31 Science Union Et Cie Arylethers and pharmaceutical compositions
DE2737630A1 (de) * 1977-08-20 1979-03-01 Boehringer Mannheim Gmbh Neue aminopropanolderivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
US4348401A (en) 1982-09-07
DE3062052D1 (en) 1983-03-24
CA1139759A (en) 1983-01-18
ES495412A0 (es) 1981-06-16
EP0026876B1 (de) 1983-02-16
CS219950B2 (en) 1983-03-25
ES8105729A1 (es) 1981-06-16
JPS5668669A (en) 1981-06-09
EP0026876A1 (de) 1981-04-15
DE2939292A1 (de) 1981-04-09
DD153117A5 (de) 1981-12-23
ATE2519T1 (de) 1983-03-15

Similar Documents

Publication Publication Date Title
IL61114A0 (en) New n-phenoxyalkylpiperidine derivatives,processes for the preparation thereof and pharmaceutical compositions containing them
IL68075A0 (en) Pyridine and pyrane derivatives,their preparation and pharmaceutical compositions containing them
ES2032750T3 (es) Profarmacos de rapamicina.
MY101359A (en) 7-acylamino-3-vinylcephalosporanic acid derivatives, processes for their preparation, pharmaceutical compositions containing them, their starting compounds and their preparation
NZ331060A (en) Quinoxalinediones, preparation and pharmaceutical compositions thereof
IE802612L (en) Bicyclo £2.2.1| heptane derivatives
SE8000205L (sv) Nya heterotricykliska derivat, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa derivat
CA2093403A1 (en) Therapeutic agent for parkinson's disease
EA200501104A1 (ru) Производные пиридина, пригодные для ингибирования системы обмена натрия/кальция
EP0096517A3 (en) Aryl pyrazinones
NZ331801A (en) Therapeutic agent for diabetes
AU572690B2 (en) Tricyclic or tetracyclic compounds, process for their preparation, and medicinal composition containing them
EP0254495A3 (en) Beta-lactam compound, method for preparing the same, medicinal composition for bacterially infectious disease therapy containing the same and intermediates for synthesis of the same
PT91607A (pt) Process for the preparation of substituted beta-diketones and of pharmaceutical compositions containing them
ES8203867A1 (es) Procedimiento para la obtencion de derivados de benzotiazol
GR3023444T3 (en) Nitrogen containing bicyclic derivatives, method for their preparation and pharmaceutical compositions containing them
DE3162053D1 (en) N-acyl peptide compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ZA836090B (en) Thieno-thiazole derivatives,processes for preparing these compounds,and pharmaceutical compositions thereof
IE800834L (en) 7-n-heterocyclyl cephalosporins
DE69110217D1 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
ES8100275A1 (es) Un procedimiento para la preparacion de derivados de 5-fluoruracilo
IL59507A (en) 5-(10-9)abeo-6-methylergoline derivatives,their preparation and pharmaceutical compositions containing them
ES8405020A1 (es) Un procedimiento para la preparacion de derivados de fosfolipidos.
EP0302633A3 (en) Beta-lactam compound, process for preparing the same, intermediate for synthesis of the same and medicinal composition for bacterially infectious disease therapy containing the same
ATE170860T1 (de) Antibiotische carbapenemverbindungen